In addition, tumor-infiltrating TRM cells express several immune checkpoint molecules (for example, CTLA-4, TIGIT, TIM-3, LAG3 and programmed cell death-1 [PD-1]), indicating that they might respond effectively to immune checkpoint blockers86,88,98. This evidence concerns the gene PDCD1 and neoplasm.